ESR1 and breast carcinoma: An estimated 252,710 new cases of female breast cancer were diagnosed in the United States in 2017 with approximately 75% of these being estrogen receptor–positive (ER+) (Osborne and Schiff, 2011; Siegel et al., 2017).